Ekf Diagnostics Holdings Plc

Ekf Diagnostics (EKF)

Buy
Sell
Company name:Ekf Diagnostics Holdings Plc
EPIC:EKFTrading Currency:GBX
Market Sector:ASM6ISIN:GB0031509804
Market Segment:AMSMShare Type:DE
WWW Address:https://www.ekfdiagnostics.com/Investors.htmlDescription:ORD 1P
Industry Sector:HEALTH CARE EQUIPMENT & SERVICES
 Price Price Change [%] Bid Offer Open High Low Volume
 42.10 images.advfn.com/imagesnew/2/gb/up 0.1 [0.24] 42.50 43.30 42.10 44.10 42.10 143,577
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 191.53 454.93 -0.00 3.47 - 12.13 - 80.20 - 30.00

Ekf Diagnostics Key Figures

(at previous day's close)
Market Cap.191.53m
Shares In Issue454.93m
Prev. Close42.00
PE Ratio12.13 
Dividend Yield-%
EPS - basic3.47p
Dividend PS-p
Dividend Cover- 
Cash Flow PS2.25p
Return On Equity (ROE)16.84%
Operating Margin26.19%
PEG Factor0.29 
EPS Growth Rate41.63%
Dividends PS Growth Rate-%
Net Debt0.04m
Gross Gearing17.70%
Quick Assets34.33m
Net Working Capital33.92m
Intangibles / Fixed Assets62.02%
Turnover PS17.99p
Pre-Tax Profit PS4.71p
Retained Profit PS3.48p
Cash PS4.47p
Net Cash PS1.47p
Net Tangible Asset Value PS *11.48p
Net Asset Value PS20.83p
Spread0.80 (1.85%) 

Ekf Diagnostics Balance Sheet

L^EKF:Liabilities+EQL^EKF:Assets

Share Price Performance

Sample Period HighLow
1 week44.1042.00
4 weeks46.4042.00
12 weeks46.4039.00
1 year80.2030.00

Share Price Chart (5 years)

Ekf Diagnostics Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week42.000.100.2442.000.0942.47
4 weeks46.40-4.30-9.2742.000.4543.31
12 weeks40.102.004.9939.000.4642.30
26 weeks34.207.9023.1030.000.6138.72
1 year74.20-32.10-43.2630.000.6645.34
3 years31.5510.5533.4416.930.8354.68
5 years25.5016.6065.1016.930.6848.86

Ekf Diagnostics Key Management Ratios

Ekf Diagnostics Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio9.68 
PE Ratio12.13 
Tobin's Q Ratio 1.77 
Tobin's Q Ratio (excl. intangibles)2.81 
Dividend Yield-%
Market-to-Book Ratio2.03 
Price-to-Pre-Tax Profit PS8.94 
Price-to-Retained Profit PS12.08 
Price-to-Cash Flow PS18.71 
Price-to-Sales PS2.34 
Price-to-Net Tangible Asset Value PS3.62 
Price-to-Cash PS9.42 
Net Working Capital PS7.46 
Price Pct to Working Capital PS5.65%
Earnings Yield8.24%
Average PE29.89 
Years in average5 
PE to PE average40.59%

Ekf Diagnostics Financial Ratios

(Leverage Ratios)
Debt Ratio6.63%
Debt-to-Equity Ratio0.07 
Debt-to-Equity Ratio (excl. Intgbl)0.13 
Debt-to-Equity Market Value0.04 
Net Gearing0.03%
Net Gearing (excl. Intangibles)0.05%
Gross Gearing17.70%
Gross Gearing (excl. Intangibles)27.83%
Gearing Under 1 Year11.86%
Gearing Under 1 Year (excl. Intgbl)18.64%
Assets/Equity1.22 
Cash/Equity21.47 
(Liquidity Ratios)
Net Working Capital to Total Assets29.47%
Current Ratio3.48 
Quick Ratio (Acid Test)2.52 
Liquidity Ratio1.49 
Cash & Equiv/Current Assets42.76%
(Solvency Ratios)
Enterprise Value178.53m
CFO/Sales0.13 
CFO/Attributable Profit0.65 
CFO/Assets0.09 
CFO/Debt0.50 
Total Debt/Equity Market Value0.11 
Total Debt/Sales0.25 
Total Debt/Pre-Tax Profit0.95 
Total Debt20.38m
Total Debt/Net Current Assets0.60%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth62.41%
5 yr Compound Earnings Growth42.53%
10 yr Compound Earnings Growth17.19%
Earn drops > 5% in 10yrs4 
Beta (60-Mnth)Beta (36-Mnth)
-0.00190.0107

Ekf Diagnostics Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)21.12%
Return On Assets (ROA)14.65%
Net Profit Margin19.37%
Assets Turnover0.76 
Return On Equity (ROE)16.84%
Return On Investment (ROI)17.29%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio18.46%
Net Income Of Revenues19.37%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.95 
Fixed Assets Turnover1.31 
Current Assets Turnover1.79 
Net Working Capital Turnover 
Inventory Turnover7.53 
(Other Operating Ratios)
Total Assets-to-Sales1.32 
Debtors-to-Sales16.84%
Debt Collection Period61.46Days

Ekf Diagnostics Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
05 May 2021InterimGBX1.1001/07/202031/12/202004/11/202105/11/202101/12/20212.10
14 Sep 2020InterimGBX1.0030/12/201930/06/202004/11/202005/11/202001/12/2020-

Ekf Diagnostics Fundamentals

 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
turnover42.54100.00%44.92100.00%65.26100.00%81.84100.00%m
pre tax profit12.1728.59%5.5212.28%15.3623.53%21.4426.19%m
attributable profit10.1123.76%3.688.19%11.1117.03%15.8519.37%m
retained profit10.1123.76%3.688.19%11.1117.03%15.8519.37%m
eps - basic (p)2.21 0.81 2.45 3.47 
eps - diluted (p)2.19 0.80 2.42 3.44 
dividends per share- - 2.10 - 

Ekf Diagnostics Balance Sheet

 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
L^EKF:Liabilities+EQL^EKF:AssetsL^EKF:Liabilities+EQL^EKF:AssetsL^EKF:Liabilities+EQL^EKF:AssetsL^EKF:Liabilities+EQL^EKF:Assets
 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
ASSETS
fixed assets fixed assets12.4715.32%12.1813.98%12.6212.46%17.8715.52%m
intangibles intangibles41.7751.33%38.7744.50%38.0737.59%41.8936.39%m
fixed investments fixed investments3.274.02%9.9011.36%6.616.53%7.796.77%m
current assets - other current assets - other--%--%--%--%m
stocks stocks6.127.51%6.076.97%8.498.38%13.2411.50%m
debtors debtors7.479.18%8.139.33%13.5713.40%13.9912.15%m
cash & securities cash & securities10.2812.63%12.0713.86%21.9121.64%20.3417.67%m
TOTAL81.38100%87.13100%101.27100%115.12100%m
LIABILITIES
creditors - short creditors - short13.6016.71%12.8614.75%19.4219.17%13.6511.86%m
creditors - long creditors - long3.874.76%3.103.56%3.653.60%6.735.84%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL17.4821.47%15.9518.31%23.0722.78%20.3817.70%m
EQUITY
ord cap, reserves ord cap, reserves63.5378.06%70.5781.00%77.6576.68%94.1281.76%m
prefs, minorities prefs, minorities0.380.46%0.600.69%0.550.55%0.620.54%m
TOTAL63.9078.53%71.1781.69%78.2077.22%94.7482.30%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Ekf Diagnostics Cash Flow Statement

31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
Operating CF8.325.1013.8110.24m
Pre-Financing CF3.402.7015.154.76m
Retained CF1.902.079.94-1.39m

Ekf Diagnostics Brokers

Broker infomation is not available for this class of stock.
Your Recent History
LSE
EKF
Ekf Diagno..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20221130 21:21:59